SRH U.S. Quality GARP ETF (SRHQ)

The SRH U.S. Quality GARP ETF (SRHQ) applies a systematic screen to identify US companies growing earnings at above-average rates while trading at valuations only slightly premium to the market — a middle path between strict value and pure growth, sometimes called growth-at-a-reasonable-price.

GARP is a philosophy with more appeal in theory than in execution. The idea: buy businesses that are genuinely expanding, but insist on a valuation discount relative to that growth. A company doubling earnings every year at 50 times earnings-to-price is growth-at-an-unreasonable price. A company with mid-single-digit earnings growth at 15 times earnings is reasonable, not growth. SRHQ aims for the sweet spot — above-average growth met with below-market multiples.

The problem is that sweet spots are crowded. Everyone wants growth at a discount. When a GARP screen finds a tranche of such stocks, the market often knows about them too, and their valuations creep upward. SRHQ manages this by systematically rebalancing its holdings, which means it will sell companies as they become expensive and buy those that become undervalued, a mechanical discipline that avoids the emotional error of holding winners too long. The rebalancing also creates turnover and tax drag, costs that come out of net returns.

SRHQ’s quality overlay ensures the fund is not simply buying cheap growth stocks with deteriorating fundamentals. Quality metrics typically include return on equity, earnings stability, balance-sheet strength, and forward-earnings revision trends. A company can grow fast while burning cash or cutting corners; the quality filter aims to exclude those cases. In practice, quality screens sometimes serve as a momentum screen in disguise — recent earnings upside leads to rising estimates, which raises quality scores, which leads the fund to buy companies that have already run. The fund’s performance hinges partly on whether its quality-plus-growth formula identifies genuine value or merely chases near-term trends.

The fund’s size — likely holding 100 to 300 stocks depending on how restrictive the screens are — balances diversification against focus. It is lean enough to meaningfully overweight the best opportunities compared to a total-market fund, but broad enough to avoid concentration risk. Sector exposure often tilts toward technology, healthcare, and other areas where growth is easiest to find, meaning SRHQ is more growth-oriented than a value index but less growth-heavy than a pure growth fund.

What makes SRHQ distinct from a simple growth or quality index is the conjunction: both growth AND reasonable price. A reader might wonder whether that discipline delivers an excess return above a plain-vanilla large-cap index, or whether the higher turnover and active monitoring costs simply replicate the index result with more friction. The answer depends on whether GARP as a factor is real and persistent. Academic evidence suggests that modest growth premiums and modest value premiums exist, but combining them into a single screen is not guaranteed to improve on either alone.

SRHQ appeals to investors who have grown skeptical of pure-growth indexes (which frequently own companies with lofty valuations and uncertain profit), who want more conviction in fundamentals than a total-market fund offers, but who lack the expertise or time to pick individual stocks. It is a middle-ground bet that disciplined systematic screens can outperform simple indexing without the fees of active management.

Evaluating SRHQ requires comparing its returns and volatility to both a broad US large-cap index and a dedicated GARP competitor. Examine the fund’s actual holdings to confirm they match the stated philosophy — stocks that are growing earnings faster than the median but not trading at extreme valuations. Request the fund’s fact sheet detailing the exact growth and valuation thresholds used in the screen, and track how those thresholds have evolved. Watch the fund’s tracking error relative to its benchmark and assess how much of that error is explained by fees versus alpha generation from factor timing. Finally, run a test: compare SRHQ’s performance in high-growth years (when growth stocks soar) and stagnant years (when value outperforms) to understand whether the fund’s valuation discipline actually saves it in downturns or simply caps returns in rallies.